louisiana glp-1 gi obstruction law firm nausea lawyer in SIDE EFFECTS OF GLP-1s: WRTV Investigates is digging into dozens of lawsuits filed in Marion County alleging drug companies "downplayed" side effects of GLP-1 medications... injectable drugs Ozempic Mounjaro Attorney in Louisiana

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] [38].Singh P, Youden B, Yang Y, Chen Y, Carrier A, Cui S, Oakes K, Servos M, Jiang R, Zhang X, Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites, ACS Applied Materials & Interfaces 13(35) (2021) 4146441472

Conclusion: Trial results and adverse event reporting systems report an infrequent incidence in patients using these medications, but this report aims to contribute to the literature describing this potential adverse event.

van Raalte DH, Bjornstad P, Persson F et al (2019) The impact of sotagliflozin on renal function, albuminuria, blood pressure, and hematocrit in adults with type 1 diabetes

The lawsuit claims that the two companies, Novo Nordisk and Eli Lilly, "knew of the association between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, including gastroparesis and gastroenteritis." Their "failure to disclose information that they possessed regarding the association between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, including gastroparesis and gastroenteritis, rendered the warnings for this medication inadequate," it continues

Early Phase 2 trial data suggests this triple mechanism produces the most aggressive weight loss of any pharmaceutical approach to date, with some dose groups achieving over 24% body weight reduction in 48 weeks